MIRVASO brimonidine 3.3 mg/g (as tartrate) gel tube

Galderma Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 27f7bc1271639451
Product Name: MIRVASO brimonidine 3.3 mg/g (as tartrate) gel tube
Artg Id: 212325
Artg Name: MIRVASO brimonidine 3.3 mg/g (as tartrate) gel tube
Sponsor: Galderma Australia Pty Ltd
Company Detail Path: /organization/galderma-australia-pty-ltd
Artg Date: 2014-08-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/19dcd32d5a2b1d256defdeac7aa086e7.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/6e05c19251b3ba1b7473040280ae4acc.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

27f7bc1271639451

Type

Standard